A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics

A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics

Background: Severe asthma (SA) with comorbid chronic rhinosinusitis with nasal polyps (CRSwNP) is frequently associated with type 2 (T2) inflammatory endotype. Consequently, therapeutic targets are T2 biologics. The present retrospective study aimed to analyze and compare the clinical efficacy of me...

Full description

Bibliographic Details
Main Authors: Ulrike Förster-Ruhrmann, MD, Dafni Stergioudi, MD, Agnieszka J. Szczepek, PhD, Joachim W. Fluhr, MD, PhD, Torsten Zuberbier, MD, PhD, Heidi Olze, MD, PhD, Karl-Christian Bergmann, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:World Allergy Organization Journal
Subjects:
Biologics
Severe asthma
Nasal polyps
T2 inflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000066

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000066

Similar Items